BDBM37582 6-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl]-N2-(4-methylphenyl)-1,3,5-triazine-2,4-diamine::6-[[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]methyl]-2-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine::6-[[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]methyl]-N2-(4-methylphenyl)-1,3,5-triazine-2,4-diamine::6-{[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl}-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine::MLS000052746::SMR000082532::[4-amino-6-[(4-piperonylpiperazino)methyl]-s-triazin-2-yl]-(p-tolyl)amine::cid_1258161
SMILES Cc1ccc(Nc2nc(N)nc(CN3CCN(Cc4ccc5OCOc5c4)CC3)n2)cc1
InChI Key InChIKey=UYYURNADXNBWIN-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37582
Affinity DataIC50: 8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
